Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 15 Jul 2021 |
2 | Reply to Exam Report (MIS-R) | 24 Jul 2021 |
3 | Journal Copy | 17 Nov 2021 |
4 | TM-O(NOTICE OF OPPOSITION) | 04 Feb 2022 |
5 | Annexure -1 under rule 46 | 28 Dec 2022 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 28 Dec 2022 |
6 | Annexure -1 under rule 46 | 28 Dec 2022 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 28 Dec 2022 |
1 | EXAMINATION REPORT | 11856155 | 22 Jul 2021 | |
2 | Opposition Notice | 13540464 | 5615121 | 25 May 2022 |
3 | Opposition Counter Statement | 13560833 | 5618014 | 28 May 2022 |
Trademark was applied on 15 July 2021 with IP India.
Proprietor of Deflamil is EMIL PHARMACEUTICAL INDUSTRIES.
Class(es) in which the trademark was applied to is 5.
Status of Deflamil is Opposed.
Application number alloted to the trademark is 5045097.
H. P. Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD